Genomics and antimicrobial resistance

Already put to use in the worldwide search for new antimicrobial agents, genomics can also contribute to better targeted treatment 

Patient perspectives: the art of good communication

In the second article covering our recent patient panel event, we consider the issue that both panellists and audience members agreed was most important

Patient perspectives: managing expectations

Following our insightful patient panel event on 6th March, we explore the importance of preparing for the highs, and lows, of genomic testing

Infectious diseases and the race to diagnosis

Researchers are exploring new techniques to tackle serious infectious diseases, and contain an outbreak before it becomes an epidemic

Hereditary haemochromatosis a 'stealth disease’

Recent genomic research has shed new light on the condition, previously thought to be low risk, prompting a review of screening regulation 

Probability, chance and genetic inheritance

When it comes to genetic inheritance from parent to offspring, there isn’t a guaranteed outcome. But there are ways to assess the possible outcomes

Counselling the code: genomic testing and insurance

Genetic counsellor Megan Rogers looks at the new Code on Genetic Testing and Insurance and what it means for patients and counsellors

HIV and the genome

Genome editing has not been without controversies, but some studies suggest it may hold the cure for patients living with HIV

Let’s talk about (biological) sex

Sex as a biological variable has not always been factored in to medical research and practice. Will that change in the era of precision medicine?

Genomics and acute myeloid leukaemia

Aggressive and complex, AML often proves a challenge for clinicians, but genomic analysis is helping in the search for targeted treatments